{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:42:58Z","timestamp":1794426178160,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01522-5","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:04:02Z","timestamp":1759827842000},"page":"765-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9376-6870","authenticated-orcid":false,"given":"Fangxiao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0330-1039","authenticated-orcid":false,"given":"Jianhuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8545-3448","authenticated-orcid":false,"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-954X","authenticated-orcid":false,"given":"Yunqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-9884","authenticated-orcid":false,"given":"Jingliao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2253-2018","authenticated-orcid":false,"given":"Jiacheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1785-5953","authenticated-orcid":false,"given":"Xiujuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3929-4384","authenticated-orcid":false,"given":"Qitong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2211-6226","authenticated-orcid":false,"given":"Xiaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-9288","authenticated-orcid":false,"given":"Yang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5398-294X","authenticated-orcid":false,"given":"Hongling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6496-6141","authenticated-orcid":false,"given":"Lijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1051-0078","authenticated-orcid":false,"given":"Huan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6446-7990","authenticated-orcid":false,"given":"Bingyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5338-2611","authenticated-orcid":false,"given":"Dehao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7923-2802","authenticated-orcid":false,"given":"Chengxiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-8377","authenticated-orcid":false,"given":"Tongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2648-9433","authenticated-orcid":false,"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4498-8888","authenticated-orcid":false,"given":"Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5991-0728","authenticated-orcid":false,"given":"Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1429-0152","authenticated-orcid":false,"given":"Yingchi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2572-6495","authenticated-orcid":false,"given":"Xiaofan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-3486","authenticated-orcid":false,"given":"Mengyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7218-0659","authenticated-orcid":false,"given":"Jinyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"1522_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","volume":"21","author":"RC Larson","year":"2021","unstructured":"Larson, R. C. & Maus, M. V. Recent advances and discoveries in the mechanisms and functions of CAR T cells. Nat. Rev. Cancer 21, 145\u2013161 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"1522_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","volume":"22","author":"TJ Laskowski","year":"2022","unstructured":"Laskowski, T. J., Biederstadt, A. & Rezvani, K. Natural killer cells in antitumour adoptive cell immunotherapy. Nat. Rev. Cancer 22, 557\u2013575 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1522_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier, E. et al. Natural killer cell therapies. Nature 626, 727\u2013736 (2024).","journal-title":"Nature"},{"key":"1522_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-60761-362-6_2","volume":"612","author":"F Cichocki","year":"2010","unstructured":"Cichocki, F. & Miller, J. S. In vitro development of human killer-immunoglobulin receptor-positive NK cells. Methods Mol. Biol. 612, 15\u201326 (2010).","journal-title":"Methods Mol. Biol."},{"key":"1522_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13045-021-01083-5","volume":"14","author":"Y Gong","year":"2021","unstructured":"Gong, Y., Klein Wolterink, R. G. J., Wang, J., Bos, G. M. J. & Germeraad, W. T. V. Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy. J. Hematol. Oncol. 14, 73 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"1522_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","volume":"121","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y. et al. In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121, 258\u2013265 (2007).","journal-title":"Immunology"},{"key":"1522_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41423-024-01145-x","volume":"21","author":"A Page","year":"2024","unstructured":"Page, A., Chuvin, N., Valladeau-Guilemond, J. & Depil, S. Development of NK cell-based cancer immunotherapies through receptor engineering. Cell. Mol. Immunol. 21, 315\u2013331 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"1522_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu, E. et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 382, 545\u2013553 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1522_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin, D. et al. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial. Nat. Med. 30, 772\u2013784 (2024).","journal-title":"Nat. Med."},{"key":"1522_CR10","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00262-023-03492-6","volume":"72","author":"P de Jonge","year":"2023","unstructured":"de Jonge, P. et al. Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia. Cancer Immunol. Immunother. 72, 3323\u20133335 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"1522_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"JA Myers","year":"2021","unstructured":"Myers, J. A. & Miller, J. S. Exploring the NK cell platform for cancer immunotherapy. Nat. Rev. Clin. Oncol. 18, 85\u2013100 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1522_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1089\/hum.2012.202","volume":"24","author":"SN De Oliveira","year":"2013","unstructured":"De Oliveira, S. N. et al. Modification of hematopoietic stem\/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy. Hum. Gene Ther. 24, 824\u2013839 (2013).","journal-title":"Hum. Gene Ther."},{"key":"1522_CR13","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.4049\/jimmunol.1801004","volume":"202","author":"S Albert","year":"2019","unstructured":"Albert, S. et al. Tonic signaling and its effects on lymphopoiesis of CAR-armed hematopoietic stem and progenitor cells. J. Immunol. 202, 1735\u20131746 (2019).","journal-title":"J. Immunol."},{"key":"1522_CR14","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood.V89.12.4337","volume":"89","author":"KA Moore","year":"1997","unstructured":"Moore, K. A., Ema, H. & Lemischka, I. R. In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 89, 4337\u20134347 (1997).","journal-title":"Blood"},{"key":"1522_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1256337","volume":"345","author":"I Fares","year":"2014","unstructured":"Fares, I. et al. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345, 1509\u20131512 (2014).","journal-title":"Science"},{"key":"1522_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.stem.2018.12.011","volume":"24","author":"A Montel-Hagen","year":"2019","unstructured":"Montel-Hagen, A. et al. Organoid-induced differentiation of conventional T cells from human pluripotent stem cells. Cell Stem Cell 24, 376\u2013389.e8 (2019).","journal-title":"Cell Stem Cell"},{"key":"1522_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41421-022-00467-2","volume":"8","author":"D Huang","year":"2022","unstructured":"Huang, D. et al. Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells. Cell Discov. 8, 121 (2022).","journal-title":"Cell Discov."},{"key":"1522_CR18","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1073\/pnas.92.15.6733","volume":"92","author":"I Riviere","year":"1995","unstructured":"Riviere, I., Brose, K. & Mulligan, R. C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92, 6733\u20136737 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1522_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/BF03401639","volume":"2","author":"H Bueler","year":"1996","unstructured":"Bueler, H. & Mulligan, R. C. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol. Med. 2, 545\u2013555 (1996).","journal-title":"Mol. Med."},{"key":"1522_CR20","first-page":"612","volume":"26","author":"FT Thiemann","year":"1998","unstructured":"Thiemann, F. T., Moore, K. A., Smogorzewska, E. M., Lemischka, I. R. & Crooks, G. M. The murine stromal cell line AFT024 acts specifically on human CD34+CD38\u2212 progenitors to maintain primitive function and immunophenotype in vitro. Exp. Hematol. 26, 612\u2013619 (1998).","journal-title":"Exp. Hematol."},{"key":"1522_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/sj.leu.2401432","volume":"13","author":"M Punzel","year":"1999","unstructured":"Punzel, M., Gupta, P., Roodell, M., Mortari, F. & Verfaillie, C. M. Factor(s) secreted by AFT024 fetal liver cells following stimulation with human cytokines are important for human LTC-IC growth. Leukemia 13, 1079\u20131084 (1999).","journal-title":"Leukemia"},{"key":"1522_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/sj.leu.2402371","volume":"16","author":"JA Nolta","year":"2002","unstructured":"Nolta, J. A. et al. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors. Leukemia 16, 352\u2013361 (2002).","journal-title":"Leukemia"},{"key":"1522_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148329","volume":"131","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. ADGRG1 enriches for functional human hematopoietic stem cells following ex vivo expansion-induced mitochondrial oxidative stress. J. Clin. Invest. 131, e148329 (2021).","journal-title":"J. Clin. Invest."},{"key":"1522_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","volume":"33","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness. Cell Res. 33, 341\u2013354 (2023).","journal-title":"Cell Res."},{"key":"1522_CR25","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/eji.201444464","volume":"44","author":"V Beziat","year":"2014","unstructured":"Beziat, V. et al. Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur. J. Immunol. 44, 2192\u20132196 (2014).","journal-title":"Eur. J. Immunol."},{"key":"1522_CR26","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","volume":"105","author":"KC Hsu","year":"2005","unstructured":"Hsu, K. C. et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105, 4878\u20134884 (2005).","journal-title":"Blood"},{"key":"1522_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13683","volume":"57","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activity. Cell Prolif. 57, e13683 (2024).","journal-title":"Cell Prolif."},{"key":"1522_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1600-065X.2006.00457.x","volume":"214","author":"YT Bryceson","year":"2006","unstructured":"Bryceson, Y. T., March, M. E., Ljunggren, H. G. & Long, E. O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214, 73\u201391 (2006).","journal-title":"Immunol. Rev."},{"key":"1522_CR29","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/eji.202049028","volume":"51","author":"L Quatrini","year":"2021","unstructured":"Quatrini, L. et al. Human NK cells, their receptors and function. Eur. J. Immunol. 51, 1566\u20131579 (2021).","journal-title":"Eur. J. Immunol."},{"key":"1522_CR30","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager, I. & Watzl, C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J. Leukoc. Biol. 105, 1319\u20131329 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"1522_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","volume":"294","author":"G Alter","year":"2004","unstructured":"Alter, G., Malenfant, J. M. & Altfeld, M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15\u201322 (2004).","journal-title":"J. Immunol. Methods"},{"key":"1522_CR32","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1002\/eji.200838830","volume":"38","author":"JP Di Santo","year":"2008","unstructured":"Di Santo, J. P. Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur. J. Immunol. 38, 2948\u20132951 (2008).","journal-title":"Eur. J. Immunol."},{"key":"1522_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388\u2013400 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"1522_CR34","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3390\/cancers12082131","volume":"12","author":"SE Franks","year":"2020","unstructured":"Franks, S. E., Wolfson, B. & Hodge, J. W. Natural born killers: NK cells in cancer therapy. Cancers 12, 2131 (2020).","journal-title":"Cancers"},{"key":"1522_CR35","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.stem.2021.08.013","volume":"28","author":"KV Woan","year":"2021","unstructured":"Woan, K. V. et al. Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy. Cell Stem Cell 28, 2062\u20132075.e5 (2021).","journal-title":"Cell Stem Cell"},{"key":"1522_CR36","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.4049\/jimmunol.175.7.4611","volume":"175","author":"R Vankayalapati","year":"2005","unstructured":"Vankayalapati, R. et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175, 4611\u20134617 (2005).","journal-title":"J. Immunol."},{"key":"1522_CR37","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.3389\/fimmu.2020.02156","volume":"11","author":"S Sivori","year":"2020","unstructured":"Sivori, S. et al. Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer. Front. Immunol. 11, 2156 (2020).","journal-title":"Front. Immunol."},{"key":"1522_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723\u2013732 (2018).","journal-title":"Nat. Immunol."},{"key":"1522_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.765667","volume":"12","author":"Y Li","year":"2021","unstructured":"Li, Y., Mateu, E. & Diaz, I. Impact of cryopreservation on viability, phenotype, and functionality of porcine PBMC. Front. Immunol. 12, 765667 (2021).","journal-title":"Front. Immunol."},{"key":"1522_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1158\/2326-6066.CIR-18-0307","volume":"7","author":"SH Baumeister","year":"2019","unstructured":"Baumeister, S. H. et al. Phase I trial of autologous CAR T cells targeting NKG2D ligands in patients with AML\/MDS and multiple myeloma. Cancer Immunol. Res. 7, 100\u2013112 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1522_CR41","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/s41375-024-02392-7","volume":"38","author":"P Derigs","year":"2024","unstructured":"Derigs, P. et al. Third-generation anti-CD19 CAR T cells for relapsed\/refractory chronic lymphocytic leukemia: a phase 1\/2 study. Leukemia 38, 2419\u20132428 (2024).","journal-title":"Leukemia"},{"key":"1522_CR42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/leu.2017.226","volume":"32","author":"E Liu","year":"2018","unstructured":"Liu, E. et al. Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. Leukemia 32, 520\u2013531 (2018).","journal-title":"Leukemia"},{"key":"1522_CR43","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41591-023-02767-w","volume":"30","author":"BL Levine","year":"2024","unstructured":"Levine, B. L. et al. Unanswered questions following reports of secondary malignancies after CAR-T cell therapy. Nat. Med. 30, 338\u2013341 (2024).","journal-title":"Nat. Med."},{"key":"1522_CR44","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1182\/blood.V87.10.4082.bloodjournal87104082","volume":"87","author":"J Wineman","year":"1996","unstructured":"Wineman, J., Moore, K., Lemischka, I. & Muller-Sieburg, C. Functional heterogeneity of the hematopoietic microenvironment: rare stromal elements maintain long-term repopulating stem cells. Blood 87, 4082\u20134090 (1996).","journal-title":"Blood"},{"key":"1522_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/345442a0","volume":"345","author":"H Yoshida","year":"1990","unstructured":"Yoshida, H. et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345, 442\u2013444 (1990).","journal-title":"Nature"},{"key":"1522_CR46","first-page":"979","volume":"22","author":"H Kodama","year":"1994","unstructured":"Kodama, H., Nose, M., Niida, S., Nishikawa, S. & Nishikawa, S. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp. Hematol. 22, 979\u2013984 (1994).","journal-title":"Exp. Hematol."},{"key":"1522_CR47","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.8066449","volume":"265","author":"T Nakano","year":"1994","unstructured":"Nakano, T., Kodama, H. & Honjo, T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098\u20131101 (1994).","journal-title":"Science"},{"key":"1522_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/1044-5323(95)90047-0","volume":"7","author":"T Nakano","year":"1995","unstructured":"Nakano, T. Lymphohematopoietic development from embryonic stem cells in vitro. Semin. Immunol. 7, 197\u2013203 (1995).","journal-title":"Semin. Immunol."},{"key":"1522_CR49","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1073\/pnas.94.8.4011","volume":"94","author":"KA Moore","year":"1997","unstructured":"Moore, K. A., Pytowski, B., Witte, L., Hicklin, D. & Lemischka, I. R. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc. Natl. Acad. Sci. USA 94, 4011\u20134016 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1522_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.exphem.2020.07.010","volume":"89","author":"C Zanetti","year":"2020","unstructured":"Zanetti, C. & Krause, D. S. \u2018Caught in the net\u2019: the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia. Exp. Hematol. 89, 13\u201325 (2020).","journal-title":"Exp. Hematol."},{"key":"1522_CR51","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1084\/jem.184.6.2301","volume":"184","author":"N Takakura","year":"1996","unstructured":"Takakura, N., Kodama, H., Nishikawa, S. & Nishikawa, S. Preferential proliferation of murine colony-forming units in culture in a chemically defined condition with a macrophage colony-stimulating factor-negative stromal cell clone. J. Exp. Med. 184, 2301\u20132309 (1996).","journal-title":"J. Exp. Med."},{"key":"1522_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1089\/cell.2015.0014","volume":"17","author":"LM Figueiredo","year":"2015","unstructured":"Figueiredo, L. M., Costa, E. B., Orellana, M. D., Picanco-Castro, V. & Covas, D. T. OP9 stromal cells proteins involved in hematoendothelial differentiation from human embryonic stem cells. Cell. Reprogram. 17, 338\u2013346 (2015).","journal-title":"Cell. Reprogram."},{"key":"1522_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50054-0","volume":"15","author":"H Donnelly","year":"2024","unstructured":"Donnelly, H. et al. Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells. Nat. Commun. 15, 5791 (2024).","journal-title":"Nat. Commun."},{"key":"1522_CR54","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.4049\/jimmunol.166.3.1684","volume":"166","author":"Q Wu","year":"2001","unstructured":"Wu, Q. et al. Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development. J. Immunol. 166, 1684\u20131689 (2001).","journal-title":"J. Immunol."},{"key":"1522_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00109-007-0195-0","volume":"85","author":"C Roth","year":"2007","unstructured":"Roth, C., Rothlin, C., Riou, S., Raulet, D. H. & Lemke, G. Stromal-cell regulation of natural killer cell differentiation. J. Mol. Med. 85, 1047\u20131056 (2007).","journal-title":"J. Mol. Med."},{"key":"1522_CR56","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1182\/blood-2009-07-228387","volume":"114","author":"J Brewin","year":"2009","unstructured":"Brewin, J. et al. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 114, 4792\u20134803 (2009).","journal-title":"Blood"},{"key":"1522_CR57","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1128\/jvi.69.12.7430-7436.1995","volume":"69","author":"FL Cosset","year":"1995","unstructured":"Cosset, F. L., Takeuchi, Y., Battini, J. L., Weiss, R. A. & Collins, M. K. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430\u20137436 (1995).","journal-title":"J. Virol."},{"key":"1522_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-62703-511-8_8","volume":"1036","author":"Y Wang","year":"2013","unstructured":"Wang, Y. et al. Identification of stem cells after transplantation. Methods Mol. Biol. 1036, 89\u201394 (2013).","journal-title":"Methods Mol. Biol."},{"key":"1522_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.omtm.2018.06.009","volume":"10","author":"M Ngom","year":"2018","unstructured":"Ngom, M. et al. UM171 enhances lentiviral gene transfer and recovery of primitive human hematopoietic cells. Mol. Ther. Methods Clin. Dev. 10, 156\u2013164 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1522_CR60","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1182\/blood.V96.4.1206.h8001206_1206_1214","volume":"96","author":"PF Kelly","year":"2000","unstructured":"Kelly, P. F., Vandergriff, J., Nathwani, A., Nienhuis, A. W. & Vanin, E. F. Highly efficient gene transfer into cord blood nonobese diabetic\/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood 96, 1206\u20131214 (2000).","journal-title":"Blood"},{"key":"1522_CR61","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1074\/jbc.M115.675033","volume":"291","author":"S Majdoul","year":"2016","unstructured":"Majdoul, S. et al. Molecular determinants of vectofusin-1 and its derivatives for the enhancement of lentivirally mediated gene transfer into hematopoietic stem\/progenitor cells. J. Biol. Chem. 291, 2161\u20132169 (2016).","journal-title":"J. Biol. Chem."},{"key":"1522_CR62","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","volume":"119","author":"BG Till","year":"2012","unstructured":"Till, B. G. et al. CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results. Blood 119, 3940\u20133950 (2012).","journal-title":"Blood"},{"key":"1522_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02925-z","volume":"19","author":"R Haderbache","year":"2021","unstructured":"Haderbache, R. et al. Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients. J. Transl. Med. 19, 265 (2021).","journal-title":"J. Transl. Med."},{"key":"1522_CR64","unstructured":"Hu, F. et al. hspc_iNK. Dataset. Genome Sequence Archive https:\/\/ngdc.cncb.ac.cn\/gsa-human\/browse\/HRA007978 (2025)."},{"key":"1522_CR65","doi-asserted-by":"publisher","unstructured":"Hu, F. et al. scRNAseq_UCB_HSPC_iNK. Source code. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15787629 (2025).","DOI":"10.5281\/zenodo.15787629"}],"updated-by":[{"DOI":"10.1038\/s41551-025-01591-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000}}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01522-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01522-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01522-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:02:43Z","timestamp":1776808963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01522-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":65,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1522"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01522-5","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41551-025-01591-6","URL":"https:\/\/doi.org\/10.1038\/s41551-025-01591-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}